Citations

Mayo Clinic

Showing 10 of 108599 citations.

Psychosocial risk factors and outcomes in patients undergoing catheter ablation for atrial fibrillation
Agarwal, Siddharth , Munir, Muhammad Bilal , Chaudhary, Amna Mohyud Din, Krishan, Satyam , Deshmukh, Abhishek , Stavrakis, Stavros , Po, Sunny S. , Al‐Kindi, Sadeer , Munir, Muhammad Bilal , Agarwal, Siddharth , DeSimone, Christopher V. , Asad, Zain Ul Abideen

Pacing and Clinical Electrophysiology | September 11, 2023 | Volume: 46 | Issue: 10 | Pages: 1242-1245

10.1111/pace.14817 | PMID 37695052 Get It

AbstractThe association of psychosocial risk factors with cardiovascular disease is well‐established, and there is a growing recognition of their influence on atrial fibrillation (AF) . A recent National Heart, Lung, and Blood Institute workshop called for transforming AF research to integrate social determinants of health. There is limited data examining the impact of psychosocial risk factors (PSRFs) on outcomes in patients with an established diagnosis of AF. Catheter ablation for AF has been shown to improve arrhythmia burden and quality of life compared with medical treatment alone. It is unknown how PSRFs affect clinical outcomes in patients undergoing AF ablation. It is important to understand this relationship, especially given the increasing adoption of catheter ablation in clinical practice.
EXPLORING THE ROLE OF CENTRAL VENOUS OXYGEN SATURATION IN THE EVALUATION AND MANAGEMENT OF SEVERE HYPOXEMIA IN MECHANICALLY VENTILATED PATIENTS
Rovati, Lucrezia , Zambrano, Claudia Castillo , Marquez, Alberto , Robbins, Kellie, Puentes, Gustavo Cortés, Kanj, Amjad N, Castillo Zambrano, Claudia , Cortes Puentes, Gustavo, Kanj, Amjad , Moraes, Alice Gallo de , Gajic, Ognjen

Shock | September 11, 2023 | Volume: 60 | Issue: 5 | Pages: 646-651

10.1097/shk.0000000000002219 | PMID 37695634 Get It

ABSTRACT Background: Although central venous oxygen saturation (ScvO2) has been used as an endpoint for the treatment of circulatory shock, its role in guiding the evaluation and treatment of patients with severe hypoxemia remains to be assessed. The aim of this study was to assess the incidence of low ScvO2 in a cohort of hypoxemic patients and the association of this finding with differences in clinical management and patient outcomes. Methods: Retrospective review of data from adult intensive care unit patients with hypoxemia who required invasive mechanical ventilation for over 24 h and had at least one ScvO2 measured within 6 h of a PaO2/FiO2 ratio <200. Results: Of 442 mechanically ventilated patients with severe hypoxemia, 249 (56%) had an ScvO2 <70%. When compared with patients with ScvO2 ≥70%, those with low ScvO2 had worse systemic oxygenation and hemodynamic parameters and were more likely to receive red blood cell transfusions (31.7% vs. 18.1%, P = 0.001), epinephrine (27.3% vs. 16.6%, P = 0.007), and inodilators. Outcomes such as median intensive care unit length of stay (7.5 vs. 8.3 days, P = 0.337) and hospital mortality (39.8% vs. 35.7%, P = 0.389) were not different between groups. When stratified by the central venous-to-arterial CO2 difference (∆PCO2), patients with a low ScvO2 and normal ∆PCO2 had lower median PaO2 and hemoglobin levels and received more red blood cell transfusions, whereas those with an increased ∆PCO2 had a lower pulse pressure and cardiac index and were more likely to receive epinephrine and milrinone. Conclusion: Low ScvO2 is frequently observed in mechanically ventilated patients with severe hypoxemia, and these patients receive different interventions. Clinicians often use therapies targeting systemic oxygen delivery to correct low ScvO2. Prospective research is needed to identify patients with severe hypoxemia that might benefit from interventions targeting systemic oxygen delivery.
Recent developments in the pathology of primary pulmonary salivary gland‐type tumours
Roden, Anja C. , Roden, Anja C , Naso, Julia

Histopathology | September 11, 2023 | Volume: 84 | Issue: 1 | Pages: 102-123

10.1111/his.15039 | PMID 37694812 Get It

Primary pulmonary salivary gland‐type tumours are rare neoplasms that are thought to arise from seromucinous glands that are located in the submucosa of large airways. These neoplasms have clinical and pathologic features that are distinct from other pulmonary neoplasms. The majority of primary pulmonary salivary gland‐type tumours are malignant, with the most common entities being mucoepidermoid carcinoma, adenoid cystic carcinoma, and epithelial‐myoepithelial carcinoma. Less commonly seen are myoepithelial carcinoma, hyalinizing clear cell carcinoma, acinic cell carcinoma, secretory carcinoma, salivary duct carcinoma, intraductal carcinoma, and polymorphous adenocarcinoma. Benign salivary gland‐type tumours of the lung include pleomorphic adenoma and sialadenoma papilliferum. Morphologic, immunophenotypic, and molecular features of these neoplasms are largely similar to salivary gland tumours elsewhere, and therefore the exclusion of metastatic disease requires clinical and radiologic correlation. However, the differential diagnostic considerations are different in the lung. The distinction of salivary gland‐type tumours from their histologic mimics is important for both prognostication and treatment decisions. Overall, salivary gland type‐tumours tend to have a more favourable outcome than other pulmonary carcinomas, although high‐grade variants exist for many of these tumour types. Recent advances in our understanding of the spectrum of salivary gland‐type tumours reported in the lung and their diversity of molecular and immunohistochemical features have helped to refine the classification of these tumours and have highlighted a few differences between salivary gland‐type tumours of the lung and those primary to other sites.
Rest and Stress Left Atrial Dysfunction in Patients with Atrial Fibrillation
Ruiz, M Rivadeneira, Ciampi, Quirino , Wierzbowska‐Drabik, Karina , Kasprzak, Jarosław D. , Kalinina, Elena , Begidova, Irina , Peteiro, Jesús , Arbucci, Rosina , Marconi, Sofia, Boshchenko, A , Merli, Elisa , Re, Federica , Daros, Clarissa Borguezan , Haberka, Maciej , Saad, Ariel K. , Djordjevic‐Dikic, Ana , Ratanasit, Nithima , Rigo, Fausto , Colonna, Paolo , Pretto, José Luis de Castro e Silva , Mori, Fabio , D’Alfonso, Maria Grazia , Ostojić, Miodrag , Stanetić, Bojan , Kovačević-Preradović, Tamara , Costantino, Fabio, Barbieri, Andréa , Citro, Rodolfo , Pitino, Annalisa , Pepi, Mauro , Pellikka, Patricia A. , Picano, Eugenio , Costantino, Marco Fabio , Ciampi, Quirino , Wierzbowska-Drabik, Karina , Kasprzak, Jaroslaw D , Begidova, Irina , Peteiro, Jesus , Arbucci, Rosina , Boshchenko, Alla , Merli, Elisa , Borguezan-Daros, Clarissa , Saad, Ariel K , Djordjevic-Dikic, Ana , de Castro E Silva Pretto, José Luis , Stanetic, Bojan , Preradović, Tamara Kovačević , Barbieri, Andrea , Citro, Rodolfo , Pepi, Mauro , Pellikka, Patricia A , Picano, Eugenio , Colonna, Paolo , Zagatina, A , Ruiz, María Rivadeneira , Lowenstein, Jorge , Manganelli, Fiore , Čelutkienė, Jelena , Morrone, Doralisa , Carerj, Scipione

Journal of Clinical Medicine | September 11, 2023 | Volume: 12 | Issue: 18 | Pages: 5893

10.3390/jcm12185893 | PMID 37762833 Get It

Background: Left atrial (LA) myopathy with paroxysmal and permanent atrial fibrillation (AF) is frequent in chronic coronary syndromes (CCS) but sometimes occult at rest and elicited by stress. Aim: This study sought to assess LA volume and function at rest and during stress across the spectrum of AF. Methods: In a prospective, multicenter, observational study design, we enrolled 3042 patients [age = 64 ± 12; 63.8% male] with known or suspected CCS: 2749 were in sinus rhythm (SR, Group 1); 191 in SR with a history of paroxysmal AF (Group 2); and 102 were in permanent AF (Group 3). All patients underwent stress echocardiography (SE). We measured left atrial volume index (LAVI) in all patients and LA Strain reservoir phase (LASr) in a subset of 486 patients. Results: LAVI increased from Group 1 to 3, both at rest (Group 1 = 27.6 ± 12.2, Group 2 = 31.6 ± 12.9, Group 3 = 43.3 ± 19.7 mL/m2, p < 0.001) and at peak stress (Group 1 = 26.2 ± 12.0, Group 2 = 31.2 ± 12.2, Group 3 = 43.9 ± 19.4 mL/m2, p < 0.001). LASr progressively decreased from Group 1 to 3, both at rest (Group 1 = 26.0 ± 8.5%, Group 2 = 23.2 ± 11.2%, Group 3 = 8.5 ± 6.5%, p < 0.001) and at peak stress (Group 1 = 26.9 ± 10.1, Group 2 = 23.8 ± 11.0 Group 3 = 10.7 ± 8.1%, p < 0.001). Stress B-lines (≥2) were more frequent in AF (Group 1 = 29.7% vs. Group 2 = 35.5% vs. Group 3 = 57.4%, p < 0.001). Inducible ischemia was less frequent in SR (Group 1 = 16.1% vs. Group 2 = 24.7% vs. Group 3 = 24.5%, p = 0.001). Conclusions: In CCS, rest and stress LA dilation and reservoir dysfunction are often present in paroxysmal and, more so, in permanent AF and are associated with more frequent inducible ischemia and pulmonary congestion during stress.
Initial Experiences with the Envoy Acclaim® Fully Implanted Cochlear Implant
Dornhoffer, James R. , Lawlor, Skye K., Saoji, Aniket A. , Driscoll, Colin L. W.

Journal of Clinical Medicine | September 11, 2023 | Volume: 12 | Issue: 18 | Pages: 5875

10.3390/jcm12185875 | PMID 37762817 Get It

Introduction: Cochlear implantation has become the standard of care for the treatment of moderate-to-profound bilateral sensorineural hearing loss. However, current technologies, all of which rely on an external sound processor, have intrinsic limitations that prevent certain activities and diagnostics, thus hampering full integration into a patient’s lifestyle. The Envoy Medical (White Bear Lake, MN, USA) Acclaim® fully implanted cochlear implant is a new device currently undergoing testing that has been designed to alleviate many of the current constraints by housing all components within the patient, thus allowing for near-constant use in many environments that are not conducive to a traditional cochlear implant. Methods: As part of an Early Feasibility Study, three adult implant candidates were implanted with the Acclaim® cochlear implant. Surgical video and photography were taken, and initial observations were recorded. Implantation with the Acclaim® device is largely similar to a traditional cochlear implant, with modifications to allow room for the implanted sensor as well as the implantation of a battery in the subcutaneous tissues of the chest. Results: This study demonstrates a step-by-step overview of implanting the Acclaim® and discusses initial insight and experiences with the first three implantations with this new device. Conclusions: All three surgeries proceeded without complication, and at activation, all three patients were hearing through their devices. Surgery is more technically challenging compared to a standard cochlear implant, but the skills needed can all be mastered by a dedicated otologic surgeon.
Bartter Syndrome: A Systematic Review of Case Reports and Case Series
Qasba, Rakhtan K. , Bucharles, Anna Carolina Flumignan, Piccoli, Maria Victoria Ferreira , Sharma, Pranjal , Banga, Akshat , Kamaraj, Balakrishnan , Kumar, Harshadayani Jagadish, Happy, Mahika Afrin, Qasba, Ruman K. , Jagirdhar, Gowthami Sai Kogilathota , Essar, Mohammad Yasir , Garg, Piyush , Reddy, Shiva Teja, Rama, Kaanthi , Surani, Salim , Kashyap, Rahul , Qasba, Ruman K , Essar, Mohammad Yasir , Garg, Piyush , Surani, Salim , Kashyap, Rahul , Qasba, Rakhtan K , Nawaz, Faisal A.

Medicina | September 11, 2023 | Volume: 59 | Issue: 9 | Pages: 1638

10.3390/medicina59091638 | PMID 37763757 Get It

Background and Objectives: Bartter syndrome (BS) is a rare group of autosomal-recessive disorders that usually presents with hypokalemic metabolic alkalosis, occasionally with hyponatremia and hypochloremia. The clinical presentation of BS is heterogeneous, with a wide variety of genetic variants. The aim of this systematic review was to examine the available literature and provide an overview of the case reports and case series on BS. Materials and Methods: Case reports/series published from April 2012 to April 2022 were searched through Pubmed, JSTOR, Cochrane, ScienceDirect, and DOAJ. Subsequently, the information was extracted in order to characterize the clinical presentation, laboratory results, treatment options, and follow-up of the patients with BS. Results: Overall, 118 patients, 48 case reports, and 9 case series (n = 70) were identified. Out of these, the majority of patients were male (n = 68). A total of 21 patients were born from consanguineous marriages. Most cases were reported from Asia (73.72%) and Europe (15.25%). In total, 100 BS patients displayed the genetic variants, with most of these being reported as Type III (n = 59), followed by Type II (n = 19), Type I (n = 14), Type IV (n = 7), and only 1 as Type V. The most common symptoms included polyuria, polydipsia, vomiting, and dehydration. Some of the commonly used treatments were indomethacin, potassium chloride supplements, and spironolactone. The length of the follow-up time varied from 1 month to 14 years. Conclusions: Our systematic review was able to summarize the clinical characteristics, presentation, and treatment plans of BS patients. The findings from this review can be effectively applied in the diagnosis and patient management of individuals with BS, rendering it a valuable resource for nephrologists in their routine clinical practice.
MEFIB‐Index and MAST‐Score in the assessment of hepatic decompensation in metabolic dysfunction‐associated steatosis liver disease—Individual participant data meta‐analyses
Noureddin, Nabil , Ajmera, Veeral , Bergstrom, Jaclyn , Bettencourt, Richele, Huang, Daniel Q. , Siddiqi, Harris , Majzoub, Abdul M., Nayfeh, Tarek , Tamaki, Nobuharu , Izumi, Namiki , Idilman, R, Gümüşsoy, Mesut , Erden, Ayşe , Idılman, Ramazan , Nakajima, Atsushi , Loomba, Rohit , Huang, Daniel Q , Ajmera, Veeral , Nayfeh, Tarek , Idilman, Ramazan , Nakajima, Atsushi , Öz, Diğdem Kuru , Loomba, Rohit

Alimentary Pharmacology & Therapeutics | September 11, 2023 | Volume: 58 | Issue: 9 | Pages: 856-865

10.1111/apt.17707 | PMID 37694993 Get It

Summary Background There are limited data regarding the longitudinal association between MEFIB‐Index (MRE combined with FIB‐4) versus MAST‐Score (MRI‐aspartate aminotransferase) and hepatic decompensation. Aim To examine the longitudinal association between MEFIB‐Index versus MAST‐Score in predicting hepatic decompensation in patients with metabolic dysfunction‐associated steatotic liver disease (MASLD). Methods This was a longitudinal, retrospective analysis of subjects from United States, Japan, and Turkey who underwent a baseline MRE and MRI‐PDFF and were followed for hepatic decompensation. Cox‐proportional hazard analyses were used to assess the association between MEFIB‐Index versus MAST‐Score with a composite primary outcome (hepatic decompensation) defined as ascites, hepatic encephalopathy, and varices needing treatment. Results This meta‐analysis of individual participants (IPDMA) included 454 patients (58% women) with a mean (±SD) age of 56.0 (±13.5) years. The MEFIB‐Index (MRE ≥3.3 kPa + FIB 4 ≥1.6) and MAST‐Score (>0.242) were positive for 34% and 9% of the sample, respectively. At baseline, 23 patients met criteria for hepatic decompensation. Among 297 patients with available longitudinal data with a median (IQR) of 4.2 (5.0) years of follow‐up, 25 incident cases met criteria for hepatic decompensation. A positive MEFIB‐Index [HR = 49.22 (95% CI: 6.23–388.64, p < 0.001)] and a positive MAST‐Score [HR = 3.86 (95% CI: 1.46–10.17, p < 0.001)] were statistically significant predictors of the incident hepatic decompensation. MEFIB‐Index ( c ‐statistic: 0.89, standard error (SE) = 0.02) was statistically superior to the MAST‐Score ( c ‐statistic: 0.81, SE = 0.03) ( p < 0.0001) in predicting hepatic decompensation. Conclusion A combination of MRI‐based biomarker and blood tests, MEFIB‐Index and MAST‐Score can predict the risk of hepatic decompensation in patients with MASLD.
Quality Measurement as a Path to High Quality Care Comment on "Quality and Performance Measurement in Primary Diabetes Care: A Qualitative Study in Urban China"
Matulis, John C. , McCoy, Rozalina G. , Matulis Iii, John C , McCoy, Rozalina Grubina

International Journal of Health Policy and Management | September 11, 2023 | Volume: 12 | Issue: No issue available | Pages: 7884

10.34172/ijhpm.2023.7884 | PMID 38618800 Get It

A rigorous evaluation of the implementation of a diabetes quality measure implementation program across community healthcare clinics in Shanghai, China, where both quality measurement and primary care delivery are relatively recent but centrally supported, identified important concerns about the meaningfulness, feasibility, and accuracy of quality measures that are relevant to all quality measurement programs. These include the importance of stakeholder involvement in measure development and implementation, the need to select measures that accurately and reliably reflect care quality, the link between incentives for improved performance and data manipulation, the necessity for scientific credibility and practical feasibility of the measure, and the assurance that measure performance can be impacted by those being evaluated. In addition to elaborating on these aspects of quality measurement, we also discuss the need for quality measures that are balanced across established domains of quality, are not burdensome to participants, and are transparent, parsimonious, nimble, and oriented around continuous evaluation and improvement.
Estimating population impact of state triage policies restricting healthcare access for older adults with chronic conditions
Nguyen, Nicholas V. , Ennis, Jackson S. , Tilburt, Jon C. , Smith, Alexander K. , Kramer, Daniel B. , Sulmasy, Daniel P., DeMartino, Erin S. , Nguyen, N.V. , Riggan, Kirsten A.

Journal of the American Geriatrics Society | September 11, 2023 | Volume: 72 | Issue: 1 | Pages: 294-296

10.1111/jgs.18589 | PMID 37694828 Get It

Evaluation of Long-Term Nutrition Outcomes After Duodenal Switch: A Systematic Review and Meta-Analysis
Nakanishi, Hayato , Al-Kordi, Mohammad, Marrero, Katie , Davis, S. Scott , Clapp, Benjamin , Ghanem, Omar M. , Abi Mosleh, Kamal , Mosleh, Kamal Abi , Kermansaravi, Mohammad

The American Surgeon™ | September 11, 2023 | Volume: 90 | Issue: 3 | Pages: 399-410

10.1177/00031348231201886 | PMID 37694730 Get It

Background Biliopancreatic diversion with duodenal switch (BPD-DS) is the most effective and durable metabolic and bariatric surgery to achieve a target weight loss. However, many surgeons are hesitant to adopt BPD-DS due to a lack of training, technical complexity, and long-term nutrition deficiencies. This meta-analysis aimed to investigate long-term nutrition outcomes after primary BPD-DS in the management of obesity. Methods Cochrane, Embase, PubMed, Scopus, and Web of Science were searched for articles from their inception to February 2023 by 2 independent reviewers using the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) system. The review was registered prospectively with PROSPERO (CRD42023391316). Results From 834 studies screened, 8 studies met the eligibility criteria, with a total of 3443 patients with obesity undergoing primary BPD-DS. At long-term follow-up (≥5 years), 25.4% of patients had vitamin A deficiency (95% CI: -.012, .520, I 2 = 94%), and 57.3% had vitamin D deficiency (95% CI: .059, 1.086, I 2 = 86%). Calcium deficiency was observed in 125 patients (22.2%, 95% CI: .061, .383, I 2 = 97%), and 69.7% had an abnormal parathyroid hormone level (95% CI: .548, .847, I 2 = 78%). Ferritin level was abnormal in 30 patients (29.0%, 95% CI: .099, .481, I 2 = 79%). Conclusions Despite displaying comparable nutrition-related outcomes to mid-term follow-up, our study demonstrated that BPD-DS could result in a high level of long-term nutrition deficiency after BPD-DS for selected patients. However, further randomized controlled studies with standardized supplementation regimens and improvement in compliance are necessary to evaluate and prevent long-term nutritional deficiencies after BPD-DS.